Our PFLISA Products
One platform. Same answers independent of plex.
Ultra-sensitive quantitation, absolute precision, and reproducibility — without trade-offs between sensitivity, multiplexing, or sample volume.
The Problem
Immunoassays shouldn’t force
trade-offs
Following screening researchers
still have to choose between:
Sensitivity vs Multiplexing
Do not trade one for the other. Get both
Exceptional Value
Get more data from your precious samples by either using less or diluting it more
Dynamic range vs Reruns
Measure a wider range of sample concentrations with one dilution
Higher Productivity
Screen your own antibodies, create custom plates from a menu or choose from pre-validated plates
The Solution: No Compromise
A fundamentally different approach
PFLISA™ is built to remove compromise completely
● Same quantitation from singleplex to multiplex
● No platform switching as your assay evolves
● Ultra-sensitivity at any plex
● Consistent results from discovery to clinical
One platform, across every stage and need
Benefits in Practice
See more, even low-abundance biology
● True picogram+ level sensitivity
● Detect what traditional ELISA misses
Use less - maximize precious samples
● ≤15 µL sample input
● High-plex without compromise
Do less rework and get answers faster
● 4–5 log dynamic range
● Fewer dilutions and reruns
Stay flexible - without disruption
● ELISA-like workflow
● One system, any plex, any pairs
● Identify biomarkers earlier in
discovery
● Simplify preclinical workflows
● Reduce assay complexity across
teams
● Standardize data across stages
Stop compromising on your data !
What this means for your research
More data
Multiplex without compromise
Better data
Ultra-sensitive quantitation
Deeper insight
Detect what others miss
Stay flexible - without disruption
Less sample
PLATFORM COMPONENTS
A fully integrated platform
